Similar Articles
741 Hepatocellular carcinoma occurrence in DAA-treated hepatitis C virus patients: Correlated or incidental? A brief review
742 Biomarkers for hepatocellular carcinoma: What’s new on the horizon?
743 Pediatric hepatocellular carcinoma
744 Changing role of histopathology in the diagnosis and management of hepatocellular carcinoma
745 Delta-like ligand 4 in hepatocellular carcinoma intrinsically promotes tumour growth and suppresses hepatitis B virus replication
746 Updates on the hepatocyte growth factor/c-Met axis in hepatocellular carcinoma and its therapeutic implications
747 Differentiation of intrahepatic cholangiocarcinoma from hepatocellular carcinoma in high-risk patients: A predictive model using contrast-enhanced ultrasound
748 Conversion therapy and suitable timing for subsequent salvage surgery for initially unresectable hepatocellular carcinoma: What is new?
749 Expansion of the hepatocellular carcinoma Milan criteria in liver transplantation: Future directions
750 Identification of a five-long non-coding RNA signature to improve the prognosis prediction for patients with hepatocellular carcinoma
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA